A detailed history of Group One Trading, L.P. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 3,169 shares of CRBU stock, worth $6,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,169
Holding current value
$6,591
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $5,133 - $16,003
3,169 New
3,169 $5,000
Q3 2023

Nov 09, 2023

SELL
$4.08 - $8.14 $632 - $1,261
-155 Reduced 17.22%
745 $3,000
Q1 2023

May 12, 2023

SELL
$4.3 - $7.78 $6,020 - $10,892
-1,400 Reduced 60.87%
900 $4,000
Q4 2022

Feb 09, 2023

SELL
$5.57 - $11.01 $3,342 - $6,606
-600 Reduced 20.69%
2,300 $14,000
Q3 2022

Nov 09, 2022

BUY
$5.34 - $12.79 $1,068 - $2,558
200 Added 7.41%
2,900 $31,000
Q2 2022

Aug 11, 2022

BUY
$5.1 - $9.74 $13,769 - $26,298
2,700 New
2,700 $15,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $127M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.